These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11060676)

  • 1. Cholic acid derivatives: novel antimicrobials.
    Savage PB; Li C
    Expert Opin Investig Drugs; 2000 Feb; 9(2):263-72. PubMed ID: 11060676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial activities of squalamine mimics.
    Kikuchi K; Bernard EM; Sadownik A; Regen SL; Armstrong D
    Antimicrob Agents Chemother; 1997 Jul; 41(7):1433-8. PubMed ID: 9210661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards squalamine mimics: synthesis and antibacterial activities of head-to-tail dimeric sterol-polyamine conjugates.
    Chen WH; Wennersten C; Moellering RC; Regen SL
    Chem Biodivers; 2013 Mar; 10(3):385-93. PubMed ID: 23495155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activities of cholic acid-derived antimicrobial agents against multidrug-resistant bacteria.
    Schmidt EJ; Boswell JS; Walsh JP; Schellenberg MM; Winter TW; Li C; Allman GW; Savage PB
    J Antimicrob Chemother; 2001 May; 47(5):671-4. PubMed ID: 11328782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial activities of amine- and guanidine-functionalized cholic acid derivatives.
    Li C; Lewis MR; Gilbert AB; Noel MD; Scoville DH; Allman GW; Savage PB
    Antimicrob Agents Chemother; 1999 Jun; 43(6):1347-9. PubMed ID: 10348750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A bioconjugate approach toward squalamine mimics: Insight into the mechanism of biological action.
    Chen WH; Shao XB; Moellering R; Wennersten C; Regen SL
    Bioconjug Chem; 2006; 17(6):1582-91. PubMed ID: 17105239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New insights into the antibacterial mechanism of action of squalamine.
    Alhanout K; Malesinki S; Vidal N; Peyrot V; Rolain JM; Brunel JM
    J Antimicrob Chemother; 2010 Aug; 65(8):1688-93. PubMed ID: 20551217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro antibacterial activity of aminosterols against multidrug-resistant bacteria from patients with cystic fibrosis.
    Alhanout K; Brunel JM; Raoult D; Rolain JM
    J Antimicrob Chemother; 2009 Oct; 64(4):810-4. PubMed ID: 19666647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and characterization of cholic acid-derived antimicrobial agents with controlled stabilities.
    Guan Q; Li C; Schmidt EJ; Boswell JS; Walsh JP; Allman GW; Savage PB
    Org Lett; 2000 Sep; 2(18):2837-40. PubMed ID: 10964378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of new 3,20-bispolyaminosteroid squalamine analogues and evaluation of their antimicrobial activities.
    Djouhri-Bouktab L; Vidal N; Rolain JM; Brunel JM
    J Med Chem; 2011 Oct; 54(20):7417-21. PubMed ID: 21905738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rifaximin combined with polymyxins: A potential regimen for selective decontamination of multidrug-resistant bacteria in the digestive tract?
    Betts JW; Phee LM; Wareham DW
    J Glob Antimicrob Resist; 2016 Mar; 4():11-15. PubMed ID: 27436386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibacterial properties of cationic steroid antibiotics.
    Savage PB; Li C; Taotafa U; Ding B; Guan Q
    FEMS Microbiol Lett; 2002 Nov; 217(1):1-7. PubMed ID: 12445638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymyxin Derivatives that Sensitize Gram-Negative Bacteria to Other Antibiotics.
    Vaara M
    Molecules; 2019 Jan; 24(2):. PubMed ID: 30641878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic Antimicrobial Activity Between the Broad Spectrum Bacteriocin Garvicin KS and Nisin, Farnesol and Polymyxin B Against Gram-Positive and Gram-Negative Bacteria.
    Chi H; Holo H
    Curr Microbiol; 2018 Mar; 75(3):272-277. PubMed ID: 29058043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of dilipid polymyxins: Investigation on the effect of hydrophobicity through its fatty acyl component.
    Domalaon R; Berry L; Tays Q; Zhanel GG; Schweizer F
    Bioorg Chem; 2018 Oct; 80():639-648. PubMed ID: 30053708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The synthesis and characterization of analogs of the antimicrobial compound squalamine: 6 beta-hydroxy-3-aminosterols synthesized from hyodeoxycholic acid.
    Jones SR; Kinney WA; Zhang X; Jones LM; Selinsky BS
    Steroids; 1996 Oct; 61(10):565-71. PubMed ID: 8910969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymyxin derivatives: a patent evaluation (WO2012168820).
    Wu H; Teng P; Niu Y; Li Q; Cai J
    Expert Opin Ther Pat; 2013 Aug; 23(8):1075-81. PubMed ID: 23806121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Squalamine, an original chemosensitizer to combat antibiotic-resistant gram-negative bacteria.
    Lavigne JP; Brunel JM; Chevalier J; Pagès JM
    J Antimicrob Chemother; 2010 Apr; 65(4):799-801. PubMed ID: 20147322
    [No Abstract]   [Full Text] [Related]  

  • 19. Neopeptide antibiotics that function as opsonins and membrane-permeabilizing agents for gram-negative bacteria.
    Tsubery H; Yaakov H; Cohen S; Giterman T; Matityahou A; Fridkin M; Ofek I
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3122-8. PubMed ID: 16048913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New Caffeic Acid Derivatives as Antimicrobial Agents: Design, Synthesis, Evaluation and Docking.
    Merlani M; Barbakadze V; Amiranashvili L; Gogilashvili L; Poroikov V; Petrou A; Geronikaki A; Ciric A; Glamoclija J; Sokovic M
    Curr Top Med Chem; 2019; 19(4):292-304. PubMed ID: 30674263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.